Acromegaly: What constitutes optimal therapy?

被引:26
作者
Frohman, LA
机构
关键词
D O I
10.1210/jc.81.2.443
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:443 / 445
页数:3
相关论文
共 22 条
[1]   EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION [J].
ALEXANDER, L ;
APPLETON, D ;
HALL, R ;
ROSS, WM ;
WILKINSON, R .
CLINICAL ENDOCRINOLOGY, 1980, 12 (01) :71-79
[2]   DOES TREATMENT OF ACROMEGALY AFFECT LIFE EXPECTANCY [J].
BATES, AS ;
VANTHOFF, W ;
JONES, JM ;
CLAYTON, RN .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (01) :1-5
[3]  
BENGTSSON BA, 1988, ACTA MED SCAND, V223, P327
[4]   RISK OF 2ND BRAIN-TUMOR AFTER CONSERVATIVE SURGERY AND RADIOTHERAPY FOR PITUITARY-ADENOMA [J].
BRADA, M ;
FORD, D ;
ASHLEY, S ;
BLISS, JM ;
CROWLEY, S ;
MASON, M ;
RAJAN, B ;
TRAISH, D .
BRITISH MEDICAL JOURNAL, 1992, 304 (6838) :1343-1346
[5]  
BURNER JOE, 1990, CLIN ENDOCRINOL OXF, V32, P65
[6]   FACTORS CONTROLLING BLOOD-CONCENTRATION OF SOMATOMEDIN-C [J].
CLEMMONS, DR ;
VANWYK, JJ .
CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1984, 13 (01) :113-143
[7]  
DINN JJ, 1985, Q J MED, V57, P833
[8]   OCTREOTIDE TREATMENT OF ACROMEGALY - A RANDOMIZED, MULTICENTER STUDY [J].
EZZAT, S ;
SNYDER, PJ ;
YOUNG, WF ;
BOYAJY, LD ;
NEWMAN, C ;
KLIBANSKI, A ;
MOLITCH, ME ;
BOYD, AE ;
SHEELER, L ;
COOK, DM ;
MALARKEY, WB ;
JACKSON, I ;
VANCE, ML ;
THORNER, MO ;
BARKAN, A ;
FROHMAN, LA ;
MELMED, S .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (09) :711-718
[9]   SURGICAL-MANAGEMENT OF ACROMEGALY [J].
FAHLBUSCH, R ;
HONEGGER, J ;
BUCHFELDER, M .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1992, 21 (03) :669-692
[10]  
FROHMAN LA, 1996, IN PRESS ONCOGENESIS